-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2011 to Q4 2024.
- Arrowhead Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending December 31, 2024 was $7.52M, a 89.1% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $141M, a 20% decline from 2023.
- Arrowhead Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $177M, a 235% increase from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $52.8M, a 124% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)